Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Rui-Liang Ge"'
Autor:
Chen-Qi Li, Yuan-Chen Wang, Shu-Qun Shen, Yan-Li Zhang, Jie-Qiong Zhao, Wen-Bin Zou, Rui-Liang Ge
Publikováno v:
Journal of Sport and Health Science, Vol 12, Iss 4, Pp 491-500 (2023)
Background: There is scant evidence regarding the effects of exercise type and duration on quality of life (QoL) in digestive system cancer (DSC) survivors. We aim to investigate the optimal type and duration of exercise to improve QoL for DSC surviv
Externí odkaz:
https://doaj.org/article/f591032892404510bd87b1c2fb6b77f5
Autor:
Zhi-Hua Xie, Xuebing Shi, Ming-Qi Liu, Jinghan Wang, Yong Yu, Ji-Xiang Zhang, Kai-Jian Chu, Wei Li, Rui-Liang Ge, Qing-Bao Cheng, Xiao-Qing Jiang
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
ObjectiveThe aim of this study was to develop and validate a nomogram to predict the overall survival of incidental gallbladder cancer.MethodsA total of 383 eligible patients with incidental gallbladder cancer diagnosed in Shanghai Eastern Hepatobili
Externí odkaz:
https://doaj.org/article/f9161a4ca7114a5c9731daba5fb10dd4
Autor:
Chen-Qi, Li, Yuan-Chen, Wang, Shu-Qun, Shen, Yan-Li, Zhang, Jie-Qiong, Zhao, Wen-Bin, Zou, Rui-Liang, Ge
Publikováno v:
Journal of Sport and Health Science.
There is scant evidence regarding the effects of exercise type and duration on quality of life (QoL) in digestive system cancer (DSC) survivors. We aim to investigate the optimal type and duration of exercises to improve QoL for DSC survivors through
Autor:
Menglong Wang, Rui-Liang Ge, Feiyang Zhang, Deng-Guang Yu, Zhe-Peng Liu, Xiaoyan Li, Hao Shen, Gareth R. Williams
Publikováno v:
Biomaterials Advances. 150:213404
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 11, Pp 603-608 (2011)
BACKGROUND: Currently, the most effective treatment for intrahepatic cholangiocarcinoma (ICC) is complete hepatic tumour excision.
Externí odkaz:
https://doaj.org/article/2d14779c36834be4a04d3c5e96694c00
Autor:
Yun-Zhang Dai, Yong-da Liu, Rui-Liang Ge, Xiao-Ning Liu, Ming-Han Li, Shu-Han Sun, Ji-hang Yuan, Jia-Li Lin, Fang Wang, Ke-Chao Zhai, Xiao-Ting Zhu, Tian-tian Wang, Jie Li
Publikováno v:
Br J Cancer
BACKGROUND: Many molecular alterations are shared by embryonic liver development and hepatocellular carcinoma (HCC). Identifying the common molecular events would provide a novel prognostic biomarker and therapeutic target for HCC. METHODS: Expressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e33ad062414c10534b15cce685408797
https://europepmc.org/articles/PMC8438090/
https://europepmc.org/articles/PMC8438090/
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 11, Pp 603-608 (2011)
BACKGROUND: Currently, the most effective treatment for intrahepatic cholangiocarcinoma (ICC) is complete hepatic tumour excision.OBJECTIVE: To identify the clinical parameters associated with survival duration for ICC patients following hepatectomy,
Publikováno v:
Academic Journal of Second Military Medical University. 30:28-32
Publikováno v:
Academic Journal of Second Military Medical University. 29:1115-1118
Publikováno v:
Acta pharmacologica Sinica. 35(1)
To investigate the roles of P21-activated kinase 5 (PAK5) in proliferation and tumorigenicity of human hepatocellular carcinoma (HCC).HCC and matched paraneoplastictis tissue samples were obtained from 30 patients. Human HCC cell lines SMMC7721, HepG